tetano
Editor, Senior Moderator
iScience
. 2025 Jul 5;28(8):113063.
doi: 10.1016/j.isci.2025.113063. eCollection 2025 Aug 15. Direct interaction of HMGB1 with SARS-CoV-2 facilitates its infection via RAGE-dependent endocytosis
Su Ful Jung[SUP] 1 2 [/SUP], Man Sup Kwak[SUP] 1 3 [/SUP], Myeonggil Han[SUP] 1 2 [/SUP], Seoyeon Choi[SUP] 1 2 [/SUP], Han Young Seo[SUP] 4 [/SUP], Jong-Won Oh[SUP] 4 [/SUP], In Ho Park[SUP] 3 5 [/SUP], Jeon-Soo Shin[SUP] 1 2 3 [/SUP]
Affiliations
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has caused >770 million infections since 2020. SARS-CoV-2 outcomes are largely influenced by host immune responses. Among key mediators of innate immunity, high-mobility group box 1 (HMGB1) has gained attention for its role in inflammation during SARS-CoV-2 infection, and its levels are significantly elevated in acute and post-COVID-19 cases, correlating with disease severity. This study investigated the role of HMGB1 in COVID-19 pathogenesis. Our findings demonstrate that the SARS-CoV-2 spike protein directly interacts with HMGB1, forming an HMGB1-SARS-CoV-2 complex. This complex interacts with the receptor for advanced glycation end-products (RAGE), facilitating clathrin-mediated endocytosis and enhancing SARS-CoV-2 infection in human lung cells in vitro and in mouse models of infection. Overall, this study demonstrates the role of HMGB1 in promoting viral entry via RAGE, emphasizing its potential as a therapeutic target in severe COVID-19 cases.
Keywords: Cell biology; Immunology; Virology.
. 2025 Jul 5;28(8):113063.
doi: 10.1016/j.isci.2025.113063. eCollection 2025 Aug 15. Direct interaction of HMGB1 with SARS-CoV-2 facilitates its infection via RAGE-dependent endocytosis
Su Ful Jung[SUP] 1 2 [/SUP], Man Sup Kwak[SUP] 1 3 [/SUP], Myeonggil Han[SUP] 1 2 [/SUP], Seoyeon Choi[SUP] 1 2 [/SUP], Han Young Seo[SUP] 4 [/SUP], Jong-Won Oh[SUP] 4 [/SUP], In Ho Park[SUP] 3 5 [/SUP], Jeon-Soo Shin[SUP] 1 2 3 [/SUP]
Affiliations
- PMID: 40740486
- PMCID: PMC12307675
- DOI: 10.1016/j.isci.2025.113063
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has caused >770 million infections since 2020. SARS-CoV-2 outcomes are largely influenced by host immune responses. Among key mediators of innate immunity, high-mobility group box 1 (HMGB1) has gained attention for its role in inflammation during SARS-CoV-2 infection, and its levels are significantly elevated in acute and post-COVID-19 cases, correlating with disease severity. This study investigated the role of HMGB1 in COVID-19 pathogenesis. Our findings demonstrate that the SARS-CoV-2 spike protein directly interacts with HMGB1, forming an HMGB1-SARS-CoV-2 complex. This complex interacts with the receptor for advanced glycation end-products (RAGE), facilitating clathrin-mediated endocytosis and enhancing SARS-CoV-2 infection in human lung cells in vitro and in mouse models of infection. Overall, this study demonstrates the role of HMGB1 in promoting viral entry via RAGE, emphasizing its potential as a therapeutic target in severe COVID-19 cases.
Keywords: Cell biology; Immunology; Virology.